TMCnet News

Sibel Health awarded a major grant to advance maternal monitoring solution for low-and-middle income countries.
[April 23, 2024]

Sibel Health awarded a major grant to advance maternal monitoring solution for low-and-middle income countries.

  • Grant support from the Bill & Melinda Gates Foundation will extend Sibel Health's AI-enabled, and FDA-cleared ANNE® One monitoring solution to improve maternal health monitoring globally
  • Sibel Health partners with the University of Edinburgh and the National Institute for Health and Care Research (NIHR) Global Health Research Unit on Global Surgery (Global Surgery Unit) to develop solutions in collaboration with leading Indian, Pakistani, and Nigerian institutes.

CHICAGO, April 23, 2024 /PRNewswire/ -- Sibel Health, an award-winning health technology company backed by the Steele Foundation for Hope, announced it has received a $17.5 million dollar grant from the Bill & Melinda Gates Foundation to advance the use of its FDA-cleared wireless monitoring solution, ANNE® One, for labor triage and continuous maternal health monitoring in low-and-middle income countries (LMICs) to reduce obstetrical morbidity and mortality. With more than 12,000 pregnancies monitored in LMICs already, Sibel Health is positioned to develop new purpose-built products in partnership with the University of Edinburgh and the NIHR Global Surgery Unit. The ANNE® One platform is an FDA-cleared platform capable of monitoring all vital signs in home and hospital settings for patients 12 years and older powered by AI-enabled advanced wearable sensors. It is Sibel's 4th FDA clearance since 2021.

"Sibel Health was spun out of Northwestern University and founded from an initial grant from the Bill & Melinda Gates Foundation given our commitment to maternal neonatal health. We're proud to come full circle to take that initial investment and expand our potential for impact. Losing a single mother while giving birth is one too many. Vital signs are vital—and every pregnant person deserves to have their vitals checked," said Steve Xu MD, CEO nd Co-Founder of Sibel Health. "We're looking forward to adding AI-driven clinical decision support and point of care ultrasound to this platform to go well beyond monitoring in the near future ." Sibel Health, founded in 2018, has been committed to maternal health innovation being recognized by the Health Resources and Services Administration as a Phase 2 winner in their Remote Pregnancy Monitoring Grand Challenge, and most recently a finalist in the NIH's Rapid Acceleration of Diagnostics Technology (RADx® Tech) for Maternal Health Challenge.

Since 2016, progress in reducing global obstetrical mortality has stalled. Currently, the goal of meeting the UN's 2030 Sustainable Development Goals of reducing maternal mortality rate to fewer than 70 out of 100,000 births is at risk. Globally, 800 women die every day in pregnancy or childbirth with the majority of these deaths being completely preventable with early detection by vital signs monitoring. In the U.S., maternal mortality has increased in the last 10 years, with black women having 3 times the risk of death compared to white women.

The University of Edinburgh is a global institution that co-leads the NIHR Global Surgery Unit. The Global Surgery Unit holds the Guinness Book of World Records as the largest biomedical collaboration ever—and will collaborate closely with Sibel Health to develop and deploy advanced maternal monitoring in 3 initial target geographies—India, Pakistan, and Nigeria. "As experts in implementing complex interventions and conducting large-scale clinical trials, we look forward to working with Sibel Health in this critical effort" said Professor Ewen Harrison, Professor of Surgery and Data Science at the University of Edinburgh, Consultant Hepatobiliary and Transplant Surgeon at the Royal Infirmary of Edinburgh, and co-lead of the NIHR Global Surgery Unit. Dr. Rosie Townsend, Senior Clinical Research Fellow at the University of Edinburgh and Consultant Obstetrician at the Royal Infirmary of Edinburgh, added "the need for vital signs monitoring is clear in maternal health for low resource settings, this is an opportunity to deliver a potentially life-saving solution."

Most recently, the Gates Foundation has invested more than $100 million dollars in bringing point of care ultrasound to LMICs for maternal health. This work extends into advanced continuous vital signs monitoring engaging leading experts based in Nigeria (Doctors Opeyemi Akinajo, Bosede Afolabi, and Adesoji Ademuyiwa), Pakistan (Doctors Zahra Hoodbhoy, Imran Nisar, and Fyezah Jehan), and India (Doctors Dhruva Ghosh and Kavita Mandrelle Bhatti) as equal partners.

About Sibel Health:
Sibel Health is an award-winning digital health company with a mission to deliver Better Health Data for All®. Based in Chicago with an international office in Seoul, the company's FDA-cleared ANNE® platform includes advanced wearable sensors, AI-enabled data analytics, and an integrated mobile software and cloud platform. Sibel has partnerships with some of the most respected healthcare organizations worldwide. For more information, please visit us at and follow us on LinkedIn.

Cision View original content to download multimedia:

SOURCE Sibel Health

[ Back To's Homepage ]